169 related articles for article (PubMed ID: 30554726)
1. Trabecular bone score and bone mineral density in patients with postsurgical hypoparathyroidism after total thyroidectomy for differentiated thyroid carcinoma.
Iglesias SG; Dominguez MLM; Herrero EF; Martinez-Pueyo JI; Arroba CM; Diaz-Guerra GM; Hawkins Carranza F
Surgery; 2019 Apr; 165(4):814-819. PubMed ID: 30554726
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow Adipose Tissue Is Increased in Postmenopausal Women With Postsurgical Hypoparathyroidism.
Diacinti D; Diacinti D; Iannacone A; Pepe J; Colangelo L; Nieddu L; Kripa E; Orlandi M; De Martino V; Minisola S; Cipriani C
J Clin Endocrinol Metab; 2023 Aug; 108(9):e807-e815. PubMed ID: 36856793
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effect of rhPTH(1-84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis.
Cipriani C; Pepe J; Silva BC; Rubin MR; Cusano NE; McMahon DJ; Nieddu L; Angelozzi M; Biamonte F; Diacinti D; Hans D; Minisola S; Bilezikian JP
J Bone Miner Res; 2018 Dec; 33(12):2132-2139. PubMed ID: 30088838
[TBL] [Abstract][Full Text] [Related]
4. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy.
Hawkins Carranza F; Guadalix Iglesias S; Luisa De Mingo Domínguez M; Martín-Arriscado Arroba C; López Álvarez B; Allo Miguel G; Martínez Díaz-Guerra G
Cancer Med; 2020 Aug; 9(16):5746-5755. PubMed ID: 32583973
[TBL] [Abstract][Full Text] [Related]
5. Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.
Sousa BÉCA; Silva BC; de Oliveira Guidotti T; Pires MC; Soares MMS; Kakehasi AM
J Endocrinol Invest; 2021 Oct; 44(10):2295-2305. PubMed ID: 33730348
[TBL] [Abstract][Full Text] [Related]
6. Bone Status Among Patients With Nonsurgical Hypoparathyroidism, Autosomal Dominant Hypocalcaemia, and Pseudohypoparathyroidism: A Cohort Study.
Underbjerg L; Malmstroem S; Sikjaer T; Rejnmark L
J Bone Miner Res; 2018 Mar; 33(3):467-477. PubMed ID: 29087612
[TBL] [Abstract][Full Text] [Related]
7. Effect of Endogenous Parathyroid Hormone on Bone Geometry and Skeletal Microarchitecture.
Hong AR; Lee JH; Kim JH; Kim SW; Shin CS
Calcif Tissue Int; 2019 Apr; 104(4):382-389. PubMed ID: 30659307
[TBL] [Abstract][Full Text] [Related]
8. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
De Mingo Dominguez ML; Guadalix Iglesias S; Martin-Arriscado Arroba C; López Alvarez B; Martínez Diaz-Guerra G; Martinez-Pueyo JI; Ferrero Herrero E; Hawkins Carranza F
Endocrine; 2018 Oct; 62(1):166-173. PubMed ID: 30014437
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone.
Duan Y; De Luca V; Seeman E
J Clin Endocrinol Metab; 1999 Feb; 84(2):718-22. PubMed ID: 10022443
[TBL] [Abstract][Full Text] [Related]
10. Risk of Fractures in Thyroid Cancer Patients With Postoperative Hypoparathyroidism: A Nationwide Cohort Study in Korea.
Ahn SH; Lee YJ; Hong S; Park JW; Jeon YJ; Yoo BN; Ha YC; Bak JK; Kim HY; Lee YK
J Bone Miner Res; 2023 Sep; 38(9):1268-1277. PubMed ID: 37338940
[TBL] [Abstract][Full Text] [Related]
11. Bone imaging in hypoparathyroidism.
Silva BC; Rubin MR; Cusano NE; Bilezikian JP
Osteoporos Int; 2017 Feb; 28(2):463-471. PubMed ID: 27577725
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
[TBL] [Abstract][Full Text] [Related]
13. Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma.
Kim CW; Hong S; Oh SH; Lee JJ; Han JY; Hong S; Kim SH; Nam M; Kim YS
J Bone Metab; 2015 Aug; 22(3):135-41. PubMed ID: 26389089
[TBL] [Abstract][Full Text] [Related]
14. Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy.
Amrein K; Dimai HP; Dobnig H; Fahrleitner-Pammer A
Osteoporos Int; 2011 Nov; 22(11):2903-5. PubMed ID: 20959964
[TBL] [Abstract][Full Text] [Related]
15. Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.
Cipriani C; Abraham A; Silva BC; Cusano NE; Rubin MR; McMahon DJ; Zhang C; Hans D; Silverberg SJ; Bilezikian JP
Endocrine; 2017 Feb; 55(2):591-598. PubMed ID: 27757772
[TBL] [Abstract][Full Text] [Related]
16. Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism.
Rubin MR; Zwahlen A; Dempster DW; Zhou H; Cusano NE; Zhang C; Müller R; Bilezikian JP
J Bone Miner Res; 2016 May; 31(5):1082-8. PubMed ID: 26724790
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density in patients with chronic hypoparathyroidism.
Abugassa S; Nordenström J; Eriksson S; Sjödén G
J Clin Endocrinol Metab; 1993 Jun; 76(6):1617-21. PubMed ID: 8501170
[TBL] [Abstract][Full Text] [Related]
19. Features of patients and fracture risk in hypoparathyroidism; a single center study.
Slutzky-Shraga I; Hirsch D; Gorshtein A; Masri-Iraqi H; Shochat T; Robenshtok E; Shimon I; Tsvetov G
J Endocrinol Invest; 2024 Mar; 47(3):593-601. PubMed ID: 37610611
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
